mmsholdings.com/ai-technology/keruscloud-clinical-trial-simulation/clinical-trial-design-analysis
MMS Holdings offers KerusCloud®, a clinical trial design and simulation platform that uses cloud-based technology to model thousands of trial scenarios in silico. The software helps sponsors optimize study designs, reduce risk, and increase the probability of success by up to 41%.
AI named KerusCloud from March 2026 to September 2026.
Brand page for mmsholdings-com-2